Fresenius Medical Care AG (ETR:FME – Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of €39.22 and traded as high as €42.54. Fresenius Medical Care shares last traded at €42.27, with a volume of 675,524 shares traded.
Fresenius Medical Care Price Performance
The firm has a 50-day moving average of €39.72 and a 200-day moving average of €39.24. The stock has a market cap of $12.64 billion, a PE ratio of 19.18, a PEG ratio of 0.42 and a beta of 0.82. The company has a debt-to-equity ratio of 83.29, a current ratio of 1.20 and a quick ratio of 0.80.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
See Also
- Five stocks we like better than Fresenius Medical Care
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
